CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-20 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +121,248 | $3.80 | $461K | 233,042 |
| 2025-10-20 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −98,934 | $38.81 | $3.8M | 134,108 |
| 2025-10-20 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −22,314 | $39.32 | $877K | 111,794 |
| 2025-10-20 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −121,248 | 136,721 | ||
| 2025-10-20 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +791 | $15.50 | $12K | 38,892 |
| 2025-10-20 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +6,195 | $12.97 | $80K | 45,087 |
| 2025-10-20 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +9,831 | $11.10 | $109K | 54,918 |
| 2025-10-20 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +9,831 | $11.97 | $118K | 64,749 |
| 2025-10-20 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +12,787 | $10.76 | $138K | 77,536 |
| 2025-10-20 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −37,255 | $38.72 | $1.4M | 40,281 |
| 2025-10-20 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −13,235 | $39.31 | $520K | 27,046 |
| 2025-10-20 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −791 | 0 | ||
| 2025-10-20 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −6,195 | 0 | ||
| 2025-10-20 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −9,831 | 0 | ||
| 2025-10-20 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −9,831 | 0 | ||
| 2025-10-20 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −12,787 | 0 | ||
| 2025-10-14 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +6,500 | $8.83 | $57K | 41,052 |
| 2025-10-14 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −11,815 | $37.65 | $445K | 29,237 |
| 2025-10-14 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −553 | $37.99 | $21K | 28,684 |
| 2025-10-14 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −6,500 | 12,500 |
Page 21 of 74 · 1,467 trades